Sector
PharmaceuticalsOpen
₹20.15Prev. Close
₹20.15Turnover(Lac.)
₹0.01Day's High
₹20.15Day's Low
₹20.1552 Week's High
₹052 Week's Low
₹0Book Value
₹-11.42Face Value
₹10Mkt Cap (₹ Cr.)
6.51P/E
0EPS
0Divi. Yield
0No Record Found
Y/e 31 Mar( In .Cr) | Jun-2013 | Mar-2012 | Mar-2011 | Mar-2010 |
---|---|---|---|---|
Equity Capital | 3.23 | 3.23 | 3.23 | 3.23 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | -1.61 | -1.27 | -1.32 | -1.29 |
Net Worth | 1.62 | 1.96 | 1.91 | 1.94 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Jun-2013 | Mar-2012 | Mar-2011 |
---|---|---|---|
Revenue | 6.38 | 9.77 | 8.75 |
yoy growth (%) | -34.65 | 11.62 | |
Raw materials | 0 | -1.32 | -1.21 |
As % of sales | 0 | 13.57 | 13.91 |
Employee costs | -1.65 | -1.52 | -1.29 |
Y/e 31 Mar( In .Cr) | Jun-2013 | Mar-2012 | Mar-2011 |
---|---|---|---|
Profit before tax | -0.27 | 0.29 | 0.05 |
Depreciation | -0.59 | -0.6 | -0.57 |
Tax paid | -0.05 | -0.24 | -0.06 |
Working capital | -1 | 1.89 | |
Other operating items |
Y/e 31 Mar | Jun-2013 | Mar-2012 | Mar-2011 |
---|---|---|---|
Growth matrix (%) | |||
Revenue growth | -34.65 | 11.62 | |
Op profit growth | -30.05 | 6.6 | |
EBIT growth | -22.48 | 35.83 | |
Net profit growth | -713.66 | -263.52 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,766.2 | 134.52 | 4,23,770.54 | 1,181.05 | 0.76 | 5,985.33 | 98.33 |
Divis Laboratories Ltd DIVISLAB | 5,958.35 | 76.3 | 1,58,175.47 | 594 | 0.5 | 2,297 | 513.62 |
Cipla Ltd CIPLA | 1,486.75 | 25.8 | 1,20,075.94 | 1,438.15 | 0.87 | 4,134.87 | 360.72 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,183 | 59.05 | 1,07,722.35 | 485 | 0.88 | 2,330 | 222.38 |
Mankind Pharma Ltd MANKIND | 2,434.1 | 51.93 | 1,00,425.74 | 416.38 | 0 | 2,396.57 | 334.17 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman
Anuj Saxena
Director
Alok Saxena
Director
Jagat Varma
Director
Ravani Mohammed Abdul Khader
Director
Kader Mohammed Davawala
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Elder Project Ltd
Summary
Elder Projects Limited manufactures injectibles in ampoules dosage form on contract basis in India. It also operates a restaurant. The company was incorporated in 1985 and it belongs to the Elder Group. The company is based in Raigad, India.
Read More
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.